RJA
ALKS icon

Raymond James & Associates’s Alkermes ALKS Stock Holding History

Raymond James & Associates’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$510K Sell
18,224
-873
-5% -$23.3K ﹤0.01% 3098
2024
Q2 		$460K Buy
19,097
+710
+4% +$17.4K ﹤0.01% 3128
2024
Q1 		$498K Buy
18,387
+470
+3% +$13.3K ﹤0.01% 3067
2023
Q4 		$497K Sell
17,917
-8,675
-33% -$225K ﹤0.01% 2960
2023
Q3 		$745K Buy
26,592
+6,510
+32% +$191K ﹤0.01% 2651
2023
Q2 		$629K Buy
20,082
+554
+3% +$16.8K ﹤0.01% 2789
2023
Q1 		$550K Sell
19,528
-354
-2% -$9.64K ﹤0.01% 2863
2022
Q4 		$520K Sell
19,882
-4,884
-20% -$117K ﹤0.01% 2878
2022
Q3 		$553K Sell
24,766
-2,220
-8% -$57.7K ﹤0.01% 2793
2022
Q2 		$804K Sell
26,986
-5,777
-18% -$166K ﹤0.01% 2595
2022
Q1 		$862K Buy
32,763
+18,667
+132% +$462K ﹤0.01% 2703
2021
Q4 		$328K Sell
14,096
-1,634
-10% -$43K ﹤0.01% 3380
2021
Q3 		$485K Buy
15,730
+6,958
+79% +$197K ﹤0.01% 3083
2021
Q2 		$215K Buy
+8,772
New +$195K ﹤0.01% 3642
2018
Q4 		– Sell
-25,031
Closed -$1.06M – 3540
2018
Q3 		$1.06M Buy
25,031
+314
+1% +$13.6K ﹤0.01% 2224
2018
Q2 		$1.02M Sell
24,717
-10,642
-30% -$485K ﹤0.01% 2201
2018
Q1 		$2.05M Buy
35,359
+10,303
+41% +$603K ﹤0.01% 1684
2017
Q4 		$1.37M Sell
25,056
-75
-0.3% -$3.83K ﹤0.01% 1939
2017
Q3 		$1.28M Buy
25,131
+710
+3% +$38K ﹤0.01% 1944
2017
Q2 		$1.42M Buy
24,421
+497
+2% +$28.9K ﹤0.01% 1806
2017
Q1 		$1.4M Sell
23,924
-54
-0.2% -$3.06K ﹤0.01% 1773
2016
Q4 		$1.33M Sell
23,978
-1,068
-4% -$57.1K ﹤0.01% 1761
2016
Q3 		$1.18M Buy
25,046
+612
+3% +$29.1K ﹤0.01% 1777
2016
Q2 		$1.06M Buy
24,434
+2,012
+9% +$83K ﹤0.01% 1710
2016
Q1 		$767K Sell
22,422
-810
-3% -$32K ﹤0.01% 1806
2015
Q4 		$1.84M Sell
23,232
-6,067
-21% -$425K 0.01% 1311
2015
Q3 		$1.72M Buy
29,299
+6,383
+28% +$421K 0.01% 1303
2015
Q2 		$1.47M Buy
+22,916
New +$1.4M 0.01% 1509
2014
Q1 		– Sell
-10,482
Closed -$426K – 2070
2013
Q4 		$426K Buy
+10,482
New +$387K ﹤0.01% 1735

Other funds holding ALKS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Raymond James & Associates's ALKS Position: Q3 2024 in Review

Raymond James & Associates reduced its Alkermes (ALKS) stake by 4.6% in Q3 2024, selling an estimated $23.3K and leaving 18,224 shares worth $510K. The position accounts for ﹤0.01% of the portfolio, ranked #3098.

Raymond James & Associates first reported a position in ALKS in Q4 2013 and has held it in 29 quarters since. The position peaked at $2.05M in Q1 2018. 338 funds tracked by Wall St. Rank hold ALKS as of Q3 2024.

  • Raymond James & Associates held 18,224 shares of Alkermes worth $510K as of Q3 2024.
  • Raymond James & Associates sold 873 Alkermes shares in Q3 2024, an estimated $23.3K.
  • Alkermes made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3098 holding.
  • Raymond James & Associates first reported a position in Alkermes in Q4 2013 and has held it in 29 quarters since.
  • Raymond James & Associates's Alkermes position peaked at $2.05M in Q1 2018.
  • 338 funds tracked by Wall St. Rank held Alkermes as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.